Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.0T | 5.2T | 5.2T | 4.0T |
Cost of revenue | 2.9T | 3.3T | 3.4T | 2.9T |
Gross profit | 1.1T | 2.0T | 1.8T | 1.1T |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 561.0B | 755.4B | 720.9B | 579.6B |
Other operating expenses | 3.6B | -25.1B | 3.7B | 3.1B |
Operating income | 272.3B | 1.0T | 797.6B | 249.5B |
Non operating interest income | ||||
Income | 58.9B | 48.0B | 26.8B | 26.0B |
Expense | 44.6B | 42.9B | 46.5B | 44.1B |
Other income expense | — | — | — | — |
Pretax income | 259.7B | 1.1T | 786.8B | 245.1B |
Tax provision | 49.0B | 181.0B | 165.6B | 48.5B |
Net income | 210.7B | 952.0B | 621.2B | 196.7B |
Basic EPS | — | — | — | — |
Diluted EPS | — | — | — | — |
Basic average shares | — | — | — | — |
Diluted average shares | — | — | — | — |
EBITDA | 376.0B | 1.2T | 898.3B | 354.2B |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |